State Street’s Sagimet Biosciences SGMT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $760K | Hold |
99,800
| – | – | ﹤0.01% | 3543 |
|
2025
Q1 | $325K | Buy |
99,800
+15,700
| +19% | +$51.2K | ﹤0.01% | 3707 |
|
2024
Q4 | $378K | Buy |
84,100
+29,900
| +55% | +$135K | ﹤0.01% | 3696 |
|
2024
Q3 | $150K | Hold |
54,200
| – | – | ﹤0.01% | 3885 |
|
2024
Q2 | $185K | Sell |
54,200
-229,152
| -81% | -$784K | ﹤0.01% | 3845 |
|
2024
Q1 | $1.54M | Buy |
283,352
+202,700
| +251% | +$1.1M | ﹤0.01% | 3363 |
|
2023
Q4 | $437K | Buy |
80,652
+50,076
| +164% | +$271K | ﹤0.01% | 3670 |
|
2023
Q3 | $269K | Buy |
+30,576
| New | +$269K | ﹤0.01% | 3847 |
|